AGÕæÈ˹ٷ½

STOCK TITAN

Intuitive Surgical Inc SEC Filings

ISRG NASDAQ

Welcome to our dedicated page for Intuitive Surgical SEC filings (Ticker: ISRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Intuitive Surgical’s disclosures run deep—hundreds of pages on da Vinci procedure volumes, FDA clearances, and patent litigation that can shift margins overnight. Finding the revenue split between system sales and high-margin instruments or spotting safety-related 8-K material events explained can consume hours. That’s the problem our platform solves.

Stock Titan delivers AI-powered summaries that turn Intuitive Surgical annual report 10-K simplified narratives into plain language and flag the exact tables analysts search for—installed base counts, per-procedure revenue, and R&D spend. Need the latest Intuitive Surgical quarterly earnings report 10-Q filing or Intuitive Surgical earnings report filing analysis? We post real-time links the moment they hit EDGAR and attach concise breakdowns of segment trends. Our engine also monitors Intuitive Surgical Form 4 insider transactions real-time, highlighting unusual executive stock transactions Form 4 within minutes, so you never miss a signal.

Whether you’re understanding Intuitive Surgical SEC documents with AI for long-term valuation or tracking Intuitive Surgical insider trading Form 4 transactions ahead of market moves, every filing type is covered. Quickly parse Intuitive Surgical proxy statement executive compensation details, review Intuitive Surgical 8-K material events explained after product recalls, and compare guidance changes across quarters. All SEC filings explained simply—so you focus on decisions, not document hunts.

Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ReTo Eco-Solutions, Inc. (RETO) has filed an amended Form 6-K to supply investors with the financial information required following its April 25, 2025 acquisition of MeinMalzeBier Holdings Limited.

The amendment adds two key exhibits:

  • Exhibit 99.1: Audited financial statements of MeinMalzeBier for fiscal years ended 31 Dec 2024 and 2023.
  • Exhibit 99.2: Unaudited pro forma condensed combined balance sheet (as of 31 Dec 2024) and income statement (FY 2024) showing RETO and MeinMalzeBier as if the transaction had closed earlier, prepared under Article 11 of Regulation S-X.

The Share Exchange, already closed on 25 Apr 2025, delivered 5,100 MeinMalzeBier ordinary shares to RETO in exchange for cash plus newly issued RETO Class A shares. No other terms were modified.

Management cautions that the pro forma data are illustrative and may differ materially from future results; numerous forward-looking risk factors are referenced. The filing is automatically incorporated by reference into RETO’s outstanding F-3 and S-8 registration statements, ensuring the new financials become part of those offerings.

Investor takeaway: The amended filing fulfils SEC requirements, provides historical audits of the acquired business and gives a first look at combined entity projections, enabling investors to start assessing acquisition accretion/dilution and balance-sheet impact once detailed numbers are reviewed in the exhibits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Intuitive Surgical (ISRG)?

The current stock price of Intuitive Surgical (ISRG) is $511 as of July 22, 2025.

What is the market cap of Intuitive Surgical (ISRG)?

The market cap of Intuitive Surgical (ISRG) is approximately 185.1B.

What does Intuitive Surgical Inc. specialize in?

Intuitive Surgical specializes in robotic-assisted, minimally invasive surgery, primarily through its da Vinci Surgical System.

How does Intuitive Surgical generate revenue?

The company generates revenue through system sales, instruments and accessories, service contracts, and training programs.

What is the da Vinci Surgical System?

The da Vinci Surgical System is a robotic platform that enhances surgical precision, dexterity, and control for minimally invasive procedures.

Who are Intuitive Surgical's competitors?

Key competitors include Medtronic and Johnson & Johnson, among others in the robotic surgery and medical device sectors.

What challenges does Intuitive Surgical face?

The company faces challenges such as regulatory approvals, market competition, and the need for continuous innovation in robotic technology.

What are the key markets for Intuitive Surgical?

Intuitive Surgical has a strong presence in the United States, Europe, Asia, and emerging markets, with thousands of systems installed globally.

What is the Ion Endoluminal System?

The Ion Endoluminal System is designed for minimally invasive pulmonary procedures, complementing Intuitive's robotic surgery portfolio.

How does Intuitive Surgical support surgeons?

The company provides training programs, advanced surgical tools, and ongoing support to help surgeons optimize their use of robotic systems.

What makes Intuitive Surgical unique?

Intuitive stands out for its extensive clinical data, proven technology, and integrated ecosystem of products and services.

What industries does Intuitive Surgical operate in?

Intuitive operates in the medical device and healthcare technology industries, focusing on robotic-assisted surgery and minimally invasive care.
Intuitive Surgical Inc

NASDAQ:ISRG

ISRG Rankings

ISRG Stock Data

185.10B
356.18M
0.52%
89.42%
1.35%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United States
SUNNYVALE